AltrixBio: Funding, Investors & Team (Sep 2026)
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric surgery.
AltrixBio has raised $5.0M across 1 funding round on record, the most recent a Series A of $5.0M announced in Sep 2025.
That round is below the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AltrixBio Company Profile and Key Stats
Latest funding round on record: Sep 2025.
AltrixBio Funding Rounds
AltrixBio Founders and Leadership Team
Contact details for the AltrixBio team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →AltrixBio Funding Compared to Other Biotechnology Startups
AltrixBio's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AltrixBio in Biotechnology and Cambridge
Companies Similar to AltrixBio
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Dayra Therapeutics manufactures peptide based medicines.
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Bexorg provides a technology platform for central nervous system drug discovery and development.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for…
Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune…
Enlaza Therapeutics is a biotechnology research company.
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
AltrixBio Funding FAQs
What does AltrixBio do?
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric surgery.
How much funding has AltrixBio raised?
AltrixBio has raised $5.0M across 1 round on record. The most recent is a Series A of $5.0M announced in Sep 2025.
When did AltrixBio last raise funding?
AltrixBio's most recent funding round on record is a Series A of $5.0M, announced in Sep 2025.
Where is AltrixBio headquartered?
AltrixBio is based in Cambridge, United States.
How many employees does AltrixBio have?
AltrixBio is in the 1-10 employee band.
How does AltrixBio's funding compare to other Biotechnology startups?
AltrixBio's latest round of $5.0M is below the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's AltrixBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AltrixBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.